Previwo would like to thank the International Symposium of Aquatic Animal Health |(ISAAH) steering committee for the opportunity to attend and present at the September 2-6th conference in Prince Edward Island, Canada. There is undoubtedly a steady increase in focus and interest on preventive measures to reduce disease and mortality in the aquaculture industry, and to improve aquatic animal health worldwide.
Previwo presented exciting results from important trials and studies and was a major sponsor, providing support of a highlight of the conference in a plenary session on ulcerative diseases of fish by Dr. Henning Sørum, Professor at the Norwegian University of Life Sciences (NMBU) . Dr. Sørum presented a focused presentation on the interaction of microbial pathogens involved in ulcerative disease in salmon, a culmination of 30 years of research into bacterial diseases in fish.
In total, Previwo had four scientific presentations in the oral sessions, with researchers Karoline Skaar Amthor, Øystein Klakegg and Aud Karin Fauske presenting trial results and highlighting the importance of good microbial maintenance by enhancing a good microbiome in aquaculture to support a healthy development of the organism, and prevent disease development in Atlantic salmon and cleaner fish.
The conference also provided the company the first opportunity to introduce the company and its first commercial product, Stembiont ™ on an international stage. Stembiont™ is a microbial enhancement bath application for better biological performance in salmon smolt entering into sea.
Our managing director, Kira Salonius was invited to present a perspective on realizing innovation in fish health sector by promoting a collaborative and open approach for advancement within the adjoining meeting Canada’s Oceans Supercluster . The Ocean Supercluster will focus $ 292 M CDN on investment on industrial, technical, and scientific innovation that will energize the economy and result in improved sustainability outcomes including a lower carbon footprint, better energy efficiency, and improved resource management in aquaculture and other ocean-based industries.
Overall, the Previwo approach has been to work together with our farming partners in industry and in research institutions to acquire a deeper and more profound understanding of host-microbial communication and interaction. We work actively to identify specific impactful bacteria that can be selected and used specifically to enhance biological performance in Atlantic salmon through application in water. We have with support from Innovation Norway IFU funding, the company has conducted safety and proof of concept studies from 2014 to 2018 enrolling more than 2 m Atlantic salmon in large scale clinical trials to develop application methods for best commercial implementation of our probiotic products. Our work continues to follow up treatment and do further research to increase our understanding of microbial enhancement and the importance of bacteria-host interaction for fish health and sustainability for the aquaculture industry. For more information on our collaborations, services or products, please see our web page Previwo.com.